WebMar 31, 2024 · Lantheus strengthened its position through an all-share takeover of Progenics in 2024. Progenics had separately disputed Endocyte’s rights to a PSMA-directed radiotherapeutic; Endocyte was acquired by Novartis. ... One of Point’s pipeline projects, PNT2004, targets FAP-alpha, though a decision has yet to be made about the … WebCompared to other companies in this collection, Lantheus is in a period of rapid growth owing to it being still a maturing company. Full year 2024 results saw a 119.9% increase in revenue to US$935.1M, lead largely by the success of PYLARIFY - their PSMA PET imaging agent - and the expansion of their Radiopharmaceutical Oncology pipeline.
Pelgifatamab corixetan - Bayer - AdisInsight - Springer
WebFeb 4, 2024 · Mark Kinarney Senior Director, Investor Relations 978-671-8842 [email protected] Melissa Downs Director, Corporate Communications 646-975-2533 [email protected] Site Navigation WebLantheus is committed to Find, Fight and Follow ® disease for patients. As part of that commitment, we ensure that Diversity, Equity and Inclusion (DEI) is a top priority when it … graham feast
Head of Product Planning Job Bedford Texas USA,Management
WebJun 2, 2024 · Latest Information Update: 02 Jun 2024. Price : $50 *. Buy Profile. Adis is an information provider. We do not sell or distribute actual drugs. Final gross price and currency may vary according to local VAT and billing address. Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. WebDec 4, 2024 · Vasovist ® has seen its production coming to an end due to insufficient sale numbers, while for example Gd-ESMA, an elastin-specific contrast agent, from Lantheus Medical Imaging (see below) is their pipeline in late-stage preclinical studies. There is a clear need for more translational efforts. WebFeb 6, 2024 · Lantheus Announces Acquisition of Cerveau Technologies, Inc., Expanding Imaging Pipeline into Alzheimer's Disease MK-6240 is an F18-labeled PET imaging agent that targets Tau tangles in Alzheimer ... graham fear solicitors